NDC 68788-9809-01 - LISINOPRIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-9809
- Requested NDC
- 68788-9809-01
- Package NDCs from labels
- 68788-9809-3, 68788-9809-6, 68788-9809-9, 68788-9809-1, 68788-9809-01
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Effective date
- 2026-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | Preferred Pharmaceuticals, Inc. | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-9809-1 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 68788-9809-3 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET | 30 | 13 | |
| 68788-9809-6 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 60 in 1 BOTTLE | TABLET | 60 | 13 | |
| 68788-9809-9 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET | 90 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-9809 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] | 11 | Current NDC, Legacy NDC, 4 package rows | 20240621_5aa18b0b-4688-493a-a5ae-cb056ea6c0e3.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 3c873a8c-b21e-448e-87f3-333419739cdd | 2025-08-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | dc177d6c-c754-4379-8c2f-1cf6f52f950a | 2025-08-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan medoxomil Amlodipine and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 52c013e1-8c31-4bed-9241-e7845873ebe8 | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 46cf633d-70a5-4d3b-b349-ad74c23ddace | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 24ee299f-4466-45d4-9013-17791e1998bb | 2025-08-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | f8b0a8ab-4549-4553-a127-bf2c0291a4b1 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 3b3c92b1-bec3-2768-e063-6394a90a9af8 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Solco Healthcare LLC | 96922ddc-e87f-4670-b22e-0ffd0d8f66e1 | 2025-07-25 | Boxed warning, Warnings, Adverse reactions | 197886 197885 197887 E7199S1YWR 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Mylan Institutional Inc. | f2a4fbc0-650b-440d-9555-c1720fe0fe35 | 2025-07-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | a04b5622-2c49-4d61-92b1-5dc523af7a24 | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | c277f1d8-2ee0-4111-adb6-38998f77dede | 2025-07-18 | Warnings | L11K75P92J |
| Lisinopril | LISINOPRIL | Major Pharmaceuticals | faade1f8-f901-40f9-a5a2-2a00e8aa94d1 | 2025-07-18 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Rena-Chord | HOMEOPATHIC LIQUID | Energetix Corporation | 4071f90a-8a28-4338-810b-c9b18cf32f87 | 2025-07-15 | Warnings | LMI26O6933 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 73bc116a-2964-4acc-9ef0-0a3f66268913 | 2025-07-14 | Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 0360db3a-17cf-4d24-97ba-e0a6fcc94351 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f4f026f9-5f21-435e-8878-01dc9bbe2d66 | 2025-07-10 | Warnings, Adverse reactions | 0J48LPH2TH |
| Schuessler Tissue Salts Calc Phos Bone Health 2 | CALCAREA PHOSPHORICA | Martin & Pleasance Pty Ltd | 81d59754-1b36-4f71-aec1-5335b003a96f | 2025-07-01 | Warnings | L11K75P92J |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | f61b4ffe-cca6-482d-88fa-adf22cb3fff2 | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| TELMISARTAN AND HYDROCHLOROTHIAZIDE | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare LLC | 47c8eee0-f0b7-4bd8-97e9-0029aa1b37db | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Slate Run Pharmaceuticals, LLC | a469adff-25a6-4983-b471-60924d920a86 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.